NewLink Genetics to Participate in the Baird Global Healthcare Conference
August 21 2018 - 8:00AM
NewLink Genetics Corporation (NASDAQ:NLNK) announced today that the
company will present at the 2018 Baird Global Healthcare Conference
on Wednesday, September 5, 2018, at 11:25AM ET.
A live webcast of the presentation will be available on the
Company’s website at www.newlinkgenetics.com in the “Investors
& Media” section under “Events and Presentations.” An
archived edition of the presentation will be available on the
Company’s website later that day.
About NewLink Genetics Corporation
NewLink Genetics is a clinical-stage
biopharmaceutical company focused on discovering, developing and
commercializing novel immuno-oncology product candidates to improve
the lives of patients with cancer. NewLink Genetics' leading drug
candidate, indoximod, is an investigational, orally available small
molecule designed to harness multiple components of the immune
system to combat cancer. For more information, please
visit www.newlinkgenetics.com and follow us on Twitter
@NLNKGenetics.
Investor Contact:
Lisa MillerDirector of Investor RelationsNewLink
Genetics515-598-2555lmiller@linkp.com
Media Contact:
Sharon CorreiaVP, Integrated
CommunicationsLaVoieHealthScience617-374-8800, ext.
105scorreia@lavoiehealthscience.com
NewLink Genetics (NASDAQ:NLNK)
Historical Stock Chart
From Apr 2024 to May 2024
NewLink Genetics (NASDAQ:NLNK)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about NewLink Genetics Corporation (NASDAQ): 0 recent articles
More News Articles